Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

Hemodialysis III: Nursing Management

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

BMJ open·2026

Same author

A patient-derived ccRCC model that retains native stromal features to assess fibrosis-driven personalized therapeutic response.

Scientific reports·2026

Same author

Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow-up.

BJUI compass·2025

Same author

Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database: The Canadian CBCIS experience.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025

Same author

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

European urology·2025

Same author

Long-term urinary complications in patients with localized prostate cancer treated with radiotherapy and/or radical prostatectomy.

World journal of urology·2025

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Thirty-day mortality after nephrectomy: clinical implications for informed consent.

Vincent Cloutier¹, Umberto Capitanio, Laurent Zini

¹Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Department of Urology, University of Montreal, Montreal, Québec, Canada.

European Urology

|December 5, 2008

Summary

Age and cancer stage are key factors influencing 30-day mortality after nephrectomy. This study developed a predictive tool to estimate mortality risk for patients undergoing kidney removal surgery.

More Related Videos

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Published on: January 27, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

Related Experiment Videos

Last Updated: Jun 27, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Published on: January 27, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

Area of Science:

Nephrology
Oncology
Surgical Outcomes

Background:

Existing literature indicates surgical mortality (SM) from nephrectomy for localized disease ranges from 0.6% to 3.6%.
Understanding 30-day mortality (TDM) is crucial for patient counseling and risk stratification.

Purpose of the Study:

To investigate age- and stage-specific 30-day mortality (TDM) rates following partial or radical nephrectomy.
To develop a predictive model for TDM based on patient and tumor characteristics.

Main Methods:

Analysis of 24,535 patients from the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) database.
Logistic regression models used to create a pretreatment prediction tool for TDM.
External validation performed on a separate cohort of 12,252 patients.

Main Results:

The overall 30-day mortality rate was 0.9% (219 deaths out of 24,535 patients).
TDM increased significantly with advancing age and higher cancer stage.
TDM rates decreased over time and were lower after partial nephrectomy compared to radical nephrectomy.
Age and stage were identified as independent predictors of TDM, with the developed model achieving 79.4% accuracy in external validation.

Conclusions:

Age and cancer stage are the primary determinants of 30-day mortality after nephrectomy.
A validated predictive model can provide individual probabilities of TDM, aiding informed consent discussions prior to surgery.